Work

Abstract 2135: QLS4131, a proprietary T cell engager targeting both BCMA and GPRC5D for the treatment of multiple myeloma

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2135

Authors: Liuqing Yang, Hongliang Qian, Juan Luo, Ke Liu, Ling Zhang, Shuyong Zhao, Hua Ying, Weikang Tao

Institution: Qilu Pharmaceutical Co., Ltd. (China)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409628815

Cites:

Cited by: 2

Related to: 10